Literature DB >> 26152289

Association between cell cycle gene transcription and tumor size in oral squamous cell carcinoma.

Marina Gonçalves Diniz1, Jeane de Fatima Correia Silva2, Fabricio Tinôco Alvim de Souza2, Núbia Braga Pereira2, Carolina Cavaliéri Gomes3, Ricardo Santiago Gomez2.   

Abstract

Higher tumor size correlates with poor prognosis and is an independent predictive survival factor in oral squamous cell carcinoma (OSCC) patients. However, the molecular events underlining OSCC tumor evolution are poorly understood. We aimed to investigate if large OSCC tumors show different cell cycle gene transcriptional signature compared to small tumors. Seventeen fresh OSCC tumor samples with different tumor sizes (T) were included in the study. Tumors were from the tongue or from the floor of the mouth, and only three patients were nonsmokers. Samples were categorized according to clinical tumor size in tumors ≤2 cm (T1, n = 5) or tumors >2 cm (T2, n = 9; T3, n = 2; T4, n = 1). The group of tumors ≤2 cm was considered the reference group, while the larger tumors were considered the test group. We assessed the expression of 84 cell cycle genes by qRT-PCR array and normalized it to the expression of two housekeeping genes. Results were analyzed according to the formula 2(^-DeltaCt). A five-fold change cutoff was used, and p values <0.05 were considered statistically significant. Ki-67 immunohistochemistry was performed to estimate cell proliferation index. Twenty-nine genes were downregulated in the test group (larger tumors) compared to the reference group (smaller tumors). Among these genes, 13 reached statistical significance: ANAPC4, CUL1, SUMO1, KPNA2, MAD2L2, CCNG2, E2F4, NBN, CUL2, PCNA, TFDP1, KNTC1, and ATR. Ki-67 labeling index was similar in both tumor groups. Our findings suggest that the transcriptional activity of specific cell cycle genes varies according to the size of OSCC tumor, which probably reflects tumor molecular evolution and adaptation to the microenvironment.

Entities:  

Keywords:  Gene expression profiling; Head and neck cancer; Molecular alteration; Oral cancer; Tumor grade; qPCR array

Mesh:

Substances:

Year:  2015        PMID: 26152289     DOI: 10.1007/s13277-015-3735-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

1.  Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.

Authors:  Deepak Kademani; R Bryan Bell; Shahrokh Bagheri; Eric Holmgren; Eric Dierks; Bryce Potter; Louis Homer
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

2.  Using Effect Size-or Why the P Value Is Not Enough.

Authors:  Gail M Sullivan; Richard Feinn
Journal:  J Grad Med Educ       Date:  2012-09

3.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

Review 4.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 5.  Targeting E3 ubiquitin ligases for cancer therapy.

Authors:  Yi Sun
Journal:  Cancer Biol Ther       Date:  2003 Nov-Dec       Impact factor: 4.742

Review 6.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

Review 7.  Cell cycle dysregulation in oral cancer.

Authors:  R Todd; P W Hinds; K Munger; A K Rustgi; O G Opitz; Y Suliman; D T Wong
Journal:  Crit Rev Oral Biol Med       Date:  2002

8.  Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.

Authors:  Paolo G Arduino; Marco Carrozzo; Andrea Chiecchio; Roberto Broccoletti; Federico Tirone; Eleonora Borra; Giorgio Bertolusso; Sergio Gandolfo
Journal:  J Oral Maxillofac Surg       Date:  2008-08       Impact factor: 1.895

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more
  4 in total

1.  Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.

Authors:  Caimei Wang; Yiyuan Wang; Congrong Liu; Xiaoyu Meng; Zhongxia Hang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  Bioinformatics Analysis of Key Genes and Pathways of Cervical Cancer.

Authors:  Huan Chen; Xi Wang; Huanhuan Jia; Yin Tao; Hong Zhou; Mingyuan Wang; Xin Wang; Xiaoling Fang
Journal:  Onco Targets Ther       Date:  2020-12-29       Impact factor: 4.147

3.  Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.

Authors:  Zheng Xu; Pan Jiang; Shengteng He
Journal:  Med Sci Monit       Date:  2019-12-03

4.  Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.

Authors:  Hong-Yan Han; Jiang-Tao Mou; Wen-Ping Jiang; Xiu-Ming Zhai; Kun Deng
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.